TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Vertex Pharmaceuticals (Sweden) AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
39,120
|
34,490
|
32,810 |
Financial expenses |
223
|
76
|
0 |
Earnings before taxes |
2,574
|
2,310
|
2,261 |
EBITDA |
3,096
|
2,398
|
2,490 |
Total assets |
21,903
|
43,796
|
29,745 |
Current assets |
21,723
|
43,269
|
29,368 |
Current liabilities |
10,915
|
34,751
|
21,828 |
Equity capital |
10,989
|
9,045
|
7,918 |
- share capital |
34
|
33
|
36 |
Employees (average) |
9
|
7
![]() |
7 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
50.2%
|
20.7%
|
26.6% |
Turnover per employee |
4,347
|
4,927
|
4,687 |
Profit as a percentage of turnover |
6.6%
|
6.7%
|
6.9% |
Return on assets (ROA) |
12.8%
|
5.4%
|
7.6% |
Current ratio |
199.0%
|
124.5%
|
134.5% |
Return on equity (ROE) |
23.4%
|
25.5%
|
28.6% |
Change turnover |
4,452
|
4,338
|
-11,435 |
Change turnover % |
13%
|
14%
|
-26% |
Chg. No. of employees |
2
|
0
|
-1 |
Chg. No. of employees % |
29%
|
0%
|
-13% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.